Subarachnoid and epidural dexmedetomidine for the prevention of post-anesthetic shivering: a meta-analysis and systematic review
Open Access
- 1 November 2019
- journal article
- review article
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 13, 3785-3798
Abstract
Background: Post-anesthetic shivering incurs discomfort to patients or even exacerbates their condition. However, no ideal drug has been well established for preventing post-anesthetic shivering. Currently, subarachnoid and epidural dexmedetomidine have demonstrated to have an anti-shivering effect. Methods: An electronic search was conducted to identify randomized placebo-controlled trials reporting shivering and then compared subarachnoid and epidural dexmedetomidine with placebo in adults undergoing selective surgery. Data assessment and pooling were analyzed by Review Manager 5.3, STATA 15.0 and GRADE-pro 3.6 software. Results: Twenty-two studies (1389 patients) were subjected to this meta-analysis. The incidence of post-anesthetic shivering decreased from 20.10% in the placebo group to 10.30% in the dexmedetomidine group (RR, 0.48; 95% CI, 0.39–0.59; Z=6.86, P5 μg showed significantly superior anti-shivering effects than that of ≤5 μg. Subarachnoid and epidural dexmedetomidine increased the incidence of bradycardia, had no impact on nausea and vomiting, shortened the onset of block and lengthened the duration of block and analgesia. However, its effect on hypotension and sedation remained uncertain. The overall risk of bias was relatively low. The level of evidence was high, and the recommendation of voting results was strong. Conclusion: Dexmedetomidine as a subarachnoid and epidural adjunct drug could decrease the incidence of post-anesthetic shivering in a dose-dependent manner. However, caution should be taken in patients with original bradycardia.Keywords
This publication has 65 references indexed in Scilit:
- The Facilitatory Effects of Intravenous Dexmedetomidine on the Duration of Spinal AnesthesiaAnesthesia & Analgesia, 2013
- The comparison of neuroprotective effects of intrathecal dexmedetomidine and metilprednisolone in spinal cord injuryInternational Journal of Surgery, 2013
- Molecular Mechanisms Underlying the Analgesic Property of Intrathecal Dexmedetomidine and Its Neurotoxicity Evaluation: An In Vivo and In Vitro Experimental StudyPLOS ONE, 2013
- Perioperative Management of Cardiovascular Implantable Electronic DevicesAnesthesia & Analgesia, 2013
- Interrater Reliability of the Bedside Shivering Assessment ScaleAmerican Journal of Critical Care, 2013
- Dexmedetomidine as an intrathecal adjuvant for postoperative analgesiaIndian Journal of Anaesthesia, 2011
- Postoperative pain status after intraoperative systemic dexmedetomidine and epidural neostigmine in patients undergoing lower abdominal surgeryEuropean Journal of Anaesthesiology, 2008
- Differential Effects of α2-adrenoceptors in the Modulation of the Thermoregulatory Response in Mice Induced by MeperidineAnesthesiology, 2008
- Independent Risk Factors for Postoperative ShiveringAnesthesia & Analgesia, 2005
- Reduction in the Shivering Threshold Is Proportional to Spinal Block HeightAnesthesiology, 1996